| Released | Contributor | Author | Title | Pages | Price |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Comprehensive Rating Report | 48 |
$99 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for QGLY | 13 |
$25 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for The Quigley Corporation | 43 |
$65 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 28-Nov-2009 | Standard & Poor's Factual Report |
N/A
| Quigley Corp | 7 |
$35 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | QUIGLEY CORP (QGLY=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | QUIGLEY CORP (QGLY=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: QUIGLEY -- QGLY | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: CPD , HSKA , OSUR , QGLY , SNTS -- DRUGS | 3 |
$4 |
0.34% Nasdaq 0.00%
Research Reports
